Assignee
CIVI BIOPHARMA INC
US·1 granted patent·3 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
4 records- 0160US12291708B2Oral delivery of antisense conjugates targeting PCSK9CIVI BIOPHARMA INC·Filed 2021·Granted May 6, 2025·0 cites·14 claims
- 0255US2026071218A1Oral Delivery of Antisense Conjugates Targeting PCSK9CIVI BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 0350US2022380761A1Oral delivery of oligonucleotidesCIVI BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0444US2024207409A1Oral delivery of oligonucleotidesCIVI BIOPHARMA INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CIVI BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →